Single-use once again growth engine for Sartorius

By Staff Reporter

- Last updated on GMT

Image: iStock/Melpomenem
Image: iStock/Melpomenem

Related tags: Bioprocess solutions division, Marketing

Sartorius reported a 22% year-on-year growth in sales in its bioprocessing division, driven by continued demand for single-use systems.

For the full year 2016, the Sartorius Group has reported total sales of €1.3bn ($1.4bn), with the company’s Bioprocess Solutions Division – described by the firm as “the growth engine in the reporting year yet again”​ – contributing €975m.

The division incorporates the firm’s portfolio of disposable upstream and downstream biomanufacturing equipment and consumables, and the 22.1% growth on 2015’s results refelects industry’s continued demand for single-use technologies.

“Our Bioprocess Solutions Division is continuing to expand strongly,”​ said CEO Joachim Kreuzburg.

“As a supplier for the biopharmaceutical industry, the division addresses a very dynamic market and is additionally gaining market share in the important North American market.”

While it was thought Europe had initially led the way in embracing single-use technologies, Sartorius reported in January 2015​ that the US had caught up. Since then the firm has continued to report double-digit quarterly growth in the business unit.

According to the firm, 2016 sales were split geographically with the EMEA representing 44% of the firm’s revenues, while the Americas made up 34%, and Asia-Pacific represented 22%.

Related news

Show more

Related products

show more

Discover the world of upstream bioprocessing

Discover the world of upstream bioprocessing

Eppendorf Bioprocess Solutions | 07-Sep-2022 | Technical / White Paper

A must-read for all bioprocess scientists: This bundle of four ebooks created by Eppendorf guides you through the world of upstream bioprocessing.

dPCR Case Study

dPCR Case Study

CellCarta | 08-Aug-2022 | Case Study

Streamline your adoptive cell therapy program with digital PCR. Our team has a unique expertise in digital and quantitative PCR to support you in ensuring...

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Related suppliers

Follow us


View more